Per Thor Straten Selected Research

Per Thor Straten Research Topics

Disease

43	Neoplasms (Cancer) 01/2024 - 03/2005
21	Melanoma (Melanoma, Malignant) 03/2021 - 10/2002
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 11/2014
4	Glioblastoma (Glioblastoma Multiforme) 06/2019 - 11/2018
4	Testicular Neoplasms (Testicular Cancer) 01/2019 - 03/2005
3	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2003
2	Inflammation (Inflammations) 03/2021 - 05/2017
2	Neoplasm Metastasis (Metastasis) 11/2020 - 10/2002
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Reinfection 01/2022
1	Disease Progression 01/2022
1	Carcinogenesis 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2021
1	Glioma (Gliomas) 01/2019
1	Ascites 01/2018
1	Hematologic Diseases (Blood Diseases) 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 12/2014
1	Ulcerative Colitis 12/2014
1	Merkel Cell Carcinoma 04/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2009
1	Hematologic Neoplasms (Hematological Malignancy) 03/2005
1	Leukemia 03/2005

Drug/Important Bio-Agent (IBA)

20	AntigensIBA 01/2022 - 03/2005
13	Peptides (Polypeptides)IBA 01/2023 - 03/2005
10	VaccinesIBA 01/2024 - 11/2008
8	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 11/2008
6	Proteins (Proteins, Gene)FDA Link 04/2014 - 03/2005
5	Chemokine ReceptorsIBA 08/2018 - 01/2016
5	EpitopesIBA 01/2014 - 03/2005
4	c-Mer Tyrosine KinaseIBA 11/2021 - 09/2019
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 10/2002
3	Interleukin-2 (IL2)IBA 01/2021 - 12/2014
3	ChemokinesIBA 01/2018 - 01/2016
2	tyrosine receptor (receptor, tyrosine)IBA 11/2021 - 03/2021
2	Phosphotransferases (Kinase)IBA 11/2021 - 03/2021
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 03/2016
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021 - 03/2016
2	Zoledronic Acid (Zometa)FDA Link 01/2021 - 01/2021
2	Protein Subunit VaccinesIBA 11/2020 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2018
2	ProteomeIBA 01/2019 - 11/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 07/2009
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 03/2005
2	Messenger RNA (mRNA)IBA 01/2016 - 01/2016
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2015 - 07/2012
2	LigandsIBA 05/2015 - 02/2011
2	EnzymesIBA 01/2014 - 08/2013
2	Inhibitor of Apoptosis ProteinsIBA 11/2012 - 08/2009
2	SurvivinIBA 11/2012 - 11/2008
1	Hormones (Hormone)IBA 01/2023
1	bcl-X ProteinIBA 01/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Recombinant ProteinsIBA 01/2021
1	Monomeric GTP-Binding ProteinsIBA 11/2020
1	Therapeutic UsesIBA 05/2020
1	HLA-A*24:02 antigenIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Chimeric Antigen ReceptorsIBA 11/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 05/2017
1	Histocompatibility Antigens Class IIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 03/2016
1	AntibodiesIBA 03/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Histocompatibility Antigens Class IIIBA 09/2015
1	HLA-A1 Antigen (HLA A1 Antigen)IBA 05/2015
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2015
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 05/2015
1	IpilimumabIBA 12/2014
1	HLA-DR Antigens (HLA-DR)IBA 11/2014
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2014
1	Tryptophan (L-Tryptophan)FDA Link 08/2013
1	Arginine (L-Arginine)FDA Link 08/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2013
1	Amino Acids FDA Link 08/2013
1	MART-1 AntigenIBA 07/2013
1	TransferasesIBA 07/2013
1	CytokinesIBA 08/2012
1	InterleukinsIBA 04/2012
1	CytosineIBA 02/2011
1	Phosphates (Orthophosphate)IBA 02/2011
1	InterferonsIBA 02/2011
1	GuanosineIBA 02/2011
1	CTLA-4 AntigenIBA 02/2011
1	Antisense OligonucleotidesIBA 08/2010
1	AutoantibodiesIBA 08/2009
1	Monoclonal AntibodiesIBA 11/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2005
1	Tumor Biomarkers (Tumor Markers)IBA 06/2003

Therapy/Procedure

18	Immunotherapy 10/2021 - 03/2005
15	Therapeutics 01/2021 - 10/2002
4	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2010 - 03/2005
1	Exercise Therapy (Therapy, Exercise) 01/2021
1	Cell Transplantation 01/2016
1	Castration 11/2014
1	ACT protocol 08/2012